Healthcare provider profile · identity verified

Corey Coles, M.D.

Internal Medicine · CREEDMOOR, NC · NPI 1255794152

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	652	188
Amlodipine Besylate	Amlodipine Besylate	486	148
Losartan Potassium	Losartan Potassium	261	81
Metformin Hcl Er	Metformin Hcl	251	83
Metoprolol Succinate	Metoprolol Succinate	203	62
Lisinopril	Lisinopril	202	63
Ozempic	Semaglutide	199	41
Omeprazole	Omeprazole	195	59
Levothyroxine Sodium	Levothyroxine Sodium	188	46
Jardiance	Empagliflozin	187	47
Pantoprazole Sodium	Pantoprazole Sodium	178	52
Gabapentin	Gabapentin	176	50
Duloxetine Hcl	Duloxetine Hcl	169	45
Trulicity	Dulaglutide	160	34
Metformin Hcl	Metformin Hcl	155	49
Pravastatin Sodium	Pravastatin Sodium	143	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	141	39
Rosuvastatin Calcium	Rosuvastatin Calcium	139	43
Furosemide	Furosemide	123	35
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	123	21
Albuterol Sulfate Hfa	Albuterol Sulfate	122	44
Trazodone Hcl	Trazodone Hcl	122	36
Hydrochlorothiazide	Hydrochlorothiazide	116	39
Tamsulosin Hcl	Tamsulosin Hcl	114	36
Allopurinol	Allopurinol	111	29
Sertraline Hcl	Sertraline Hcl	105	28
Carvedilol	Carvedilol	104	32
Ezetimibe	Ezetimibe	101	26
Eliquis	Apixaban	92	25
Glipizide Er	Glipizide	82	24
Bupropion Xl	Bupropion Hcl	79	20
Fluticasone Propionate	Fluticasone Propionate	79	35
Potassium Chloride	Potassium Chloride	77	26
Diclofenac Sodium	Diclofenac Sodium	75	33
Alendronate Sodium	Alendronate Sodium	70	24
Spironolactone	Spironolactone	68	23
Prednisone	Prednisone	63	51
Famotidine	Famotidine	55	18
Pioglitazone Hcl	Pioglitazone Hcl	54	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	17
Mirtazapine	Mirtazapine	53	13
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Pregabalin	Pregabalin	50	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	49	16
Triamcinolone Acetonide	Triamcinolone Acetonide	49	27
Clopidogrel	Clopidogrel Bisulfate	48	18
Telmisartan	Telmisartan	46	14
Montelukast Sodium	Montelukast Sodium	45	12
Warfarin Sodium	Warfarin Sodium	42	14
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Finasteride	Finasteride	41	16
Glimepiride	Glimepiride	41	suppressed
Chlorthalidone	Chlorthalidone	40	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	17
Paroxetine Hcl	Paroxetine Hcl	38	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	35
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	25
Xarelto	Rivaroxaban	35	11
Tramadol Hcl	Tramadol Hcl	33	suppressed
Klor-Con M20	Potassium Chloride	32	suppressed
Alprazolam	Alprazolam	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Hydrocortisone	Hydrocortisone	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Colchicine	Colchicine	24	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	12
Fluconazole	Fluconazole	23	18
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Lorazepam	Lorazepam	22	suppressed
Nystatin	Nystatin	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Diazepam	Diazepam	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Baclofen	Baclofen	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Cephalexin	Cephalexin	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Methimazole	Methimazole	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	11
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Simvastatin	Simvastatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error